Type | Indexed | Publication . Mgi Jnum | J:190859 |
Publication . Citation | Albanesi M, et al. (2012) Cutting Edge: FcgammaRIII (CD16) and FcgammaRI (CD64) Are Responsible for Anti-Glycoprotein 75 Monoclonal Antibody TA99 Therapy for Experimental Metastatic B16 Melanoma. J Immunol 189(12):5513-7 |